Search results
Results from the WOW.Com Content Network
Pomalidomide, sold under the brand names Pomalyst and Imnovid, [7] [8] is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. [ 7 ] Pomalidomide was approved for medical use in the United States in February 2013, [ 10 ] and in the European Union in August 2013. [ 8 ]
Antibiotic use is common in older people, with those over age 65 consuming 50% more antibiotics than younger adults. ... the bacteria that cause ... confused and this transient confusion from an ...
Haloperidol, a known cause of NMS: Specialty: Critical care medicine, neurology, psychiatry: Symptoms: High fever, confusion, rigid muscles, variable blood pressure, sweating [1] Complications: Rhabdomyolysis, high blood potassium, kidney failure, seizures [1] [2] Usual onset: Within a few weeks or days [3] Causes: Antipsychotic medication [1 ...
The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.
Nearly one in five new cervical cancers diagnosed from 2009 to 2018 were in women 65 and older, according to a new UC Davis study.But what has experts concerned is that, according to the study ...
Older adults and people who are immunocompromised (including people with type 1 and type 2 diabetes, people who are pregnant, those with cancer, and more groups) are now encouraged to get two ...
Delirium (formerly acute confusional state, an ambiguous term that is now discouraged) [1] is a specific state of acute confusion attributable to the direct physiological consequence of a medical condition, effects of a psychoactive substance, or multiple causes, which usually develops over the course of hours to days.
Menopause is a natural decline in the ovarian function of women who reach the age between 45 and 54 years. "About 25 million women pass through menopause worldwide each year, and it has been estimated that, by the year 2030, the world population of menopausal and postmenopausal women will be 1.2 billion, with 47 million new entrants each year."